CAR T Cell Clinical Trial Aims to Cure HIV,UC Davis Health researchers have dosed...
multiple myeloma
Mayo Clinic's New Strategy: Regenerative Biotherapeutics,SCOTTSDALE, Ariz. – Mayo Clinic has made significant strides...
Clinical trial gives singer more time with band,The next time you find yourself at...
Novel Drug Shows Early Promise in Treating Multiple Myeloma,NEW ORLEANS – A first-of-its-kind drug...
Novel Drug Shows Promising Results for Multiple Myeloma Treatment,NEW ORLEANS – A first-of-its-kind drug...
Experimental Cancer Therapy: 70% Success in Global Clinical Trials,A new therapy that makes the...
New Technique Can Detect and Analyze Tumor Cells of Multiple Myeloma and Precursor Conditions...
Cancer Therapy Successful in 70% of Patients Worldwide,A new therapy that makes the immune...
Possible therapeutic approach to fight incurable blood cancer,Multiple myeloma (MM) is the second most...
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial,Pfizer Inc. (NYSE:PFE)...
New Technique Can Detect and Analyze Tumor Cells of Multiple Myeloma and Precursor Conditions...
Novel PET Agent Effectively Detects Multiple Cancers, Identifies Patients for Targeted Therapies,Reston, VA-A new...
Unraveling Cancer's Complexities,“Frontiers of Medical Research: Cancer,” a Science magazine supplement published on November...
Bariatric Surgery Decreases Risk of Heart Disease,Rutgers study shows post-bariatric surgery benefits in cardiovascular...
Study shows that immune system holds clues to patients with high-risk smoldering myeloma likely...
Novel PET Agent Effectively Detects Multiple Cancers, Identifies Patients for Targeted Therapies,Reston, VA-A new...
Big data used to identify existing drugs that could be repurposed for broader medical...
Study shows that immune system holds clues to patients with high-risk smoldering myeloma likely...
“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells,In recent years, genetically re-engineered immune...
Pfizer's Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma,Pfizer Inc....
